Livzon Pharmaceutical Group Inc (000513) — Cash Flow Quality Index
Livzon Pharmaceutical Group Inc (000513) has a Cash Flow Quality Index of 2.32x as of December 2025. Operating cash flow of CN¥625.70 Million exceeds net income of CN¥269.15 Million, indicating high earnings quality where cash backs reported profits. Explore 000513 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Livzon Pharmaceutical Group Inc Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Livzon Pharmaceutical Group Inc across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Livzon Pharmaceutical Group Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Livzon Pharmaceutical Group Inc (1998–2025)
Year-by-year earnings quality comparison for Livzon Pharmaceutical Group Inc. For live market cap and the full company financial profile, see market cap of Livzon Pharmaceutical Group Inc.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.57x | CN¥3.18 Billion | CN¥2.02 Billion | ▲ +21.6% |
| 2024 | 1.29x | CN¥2.98 Billion | CN¥2.30 Billion | ▼ -24.5% |
| 2023 | 1.71x | CN¥3.25 Billion | CN¥1.90 Billion | ▲ +20.8% |
| 2022 | 1.42x | CN¥2.77 Billion | CN¥1.96 Billion | ▲ +45.5% |
| 2021 | 0.97x | CN¥1.90 Billion | CN¥1.95 Billion | ▼ -3.9% |
| 2020 | 1.01x | CN¥2.16 Billion | CN¥2.13 Billion | ▼ -16.2% |
| 2019 | 1.21x | CN¥1.77 Billion | CN¥1.46 Billion | ▲ +3.2% |
| 2018 | 1.17x | CN¥1.27 Billion | CN¥1.08 Billion | ▲ +294.2% |
| 2017 | 0.30x | CN¥1.32 Billion | CN¥4.43 Billion | ▼ -81.8% |
| 2016 | 1.63x | CN¥1.28 Billion | CN¥784.35 Million | ▲ +9.5% |
| 2015 | 1.49x | CN¥927.79 Million | CN¥622.64 Million | ▲ +15.0% |
| 2014 | 1.30x | CN¥717.39 Million | CN¥553.62 Million | ▲ +54.3% |
| 2013 | 0.84x | CN¥439.99 Million | CN¥523.99 Million | ▼ -32.8% |
| 2012 | 1.25x | CN¥593.96 Million | CN¥475.22 Million | ▼ -31.6% |
| 2011 | 1.83x | CN¥708.20 Million | CN¥387.80 Million | ▲ +30.5% |
| 2010 | 1.40x | CN¥633.30 Million | CN¥452.49 Million | ▲ +45.3% |
| 2009 | 0.96x | CN¥494.88 Million | CN¥513.79 Million | ▼ -79.7% |
| 2008 | 4.73x | CN¥345.18 Million | CN¥72.91 Million | ▲ +896.9% |
| 2007 | 0.47x | CN¥248.55 Million | CN¥523.38 Million | ▼ -68.7% |
| 2006 | 1.52x | CN¥226.46 Million | CN¥149.33 Million | ▲ +9.5% |
| 2005 | 1.39x | CN¥161.07 Million | CN¥116.27 Million | ▲ +2.9% |
| 2004 | 1.35x | CN¥181.46 Million | CN¥134.74 Million | ▼ -45.5% |
| 2003 | 2.47x | CN¥300.01 Million | CN¥121.47 Million | ▼ -0.2% |
| 2002 | 2.48x | CN¥213.65 Million | CN¥86.32 Million | ▲ +19.2% |
| 2001 | 2.08x | CN¥155.15 Million | CN¥74.71 Million | ▲ +39.7% |
| 2000 | 1.49x | CN¥38.52 Million | CN¥25.90 Million | ▼ -94.5% |
| 1999 | 27.25x | CN¥246.23 Million | CN¥9.04 Million | ▲ +6209.8% |
| 1998 | -0.45x | CN¥-18.21 Million | CN¥40.83 Million | — |